Recital 50, Regulation (EU) 2026/372

In forcesince 20 Feb 2026

It is therefore likely for all of the active substances covered by this Regulation that no decision on the renewal of the approval can be taken before the expiry of their respective approval periods, between 15 April and 31 July 2026.